Silibinin-mediated metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth.
Shukla SK, Dasgupta A, Mehla K, Gunda V, Vernucci E, Souchek J, Goode G, King R, Mishra A, Rai I, Nagarajan S, Chaika NV, Yu F, Singh PK.
Shukla SK, et al. Among authors: singh pk.
Oncotarget. 2015 Dec 1;6(38):41146-61. doi: 10.18632/oncotarget.5843.
Oncotarget. 2015.
PMID: 26510913
Free PMC article.